ACP
CVS icon

Ashfield Capital Partners’s CVS Health CVS Stock Holding History

Ashfield Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,148
Closed -$206K – 245
2018
Q4 		$206K Buy
+3,148
New +$235K 0.03% 231
2017
Q3 		– Sell
-8,820
Closed -$710K – 252
2017
Q2 		$710K Sell
8,820
-2,012
-19% -$159K 0.1% 167
2017
Q1 		$850K Sell
10,832
-2,870
-21% -$229K 0.12% 153
2016
Q4 		$1.08M Sell
13,702
-14,765
-52% -$1.19M 0.11% 139
2016
Q3 		$2.53M Sell
28,467
-1,679
-6% -$158K 0.21% 96
2016
Q2 		$2.89M Sell
30,146
-247
-0.8% -$24.6K 0.23% 86
2016
Q1 		$3.15M Sell
30,393
-526
-2% -$51.1K 0.23% 92
2015
Q4 		$3.02M Sell
30,919
-1,121
-3% -$110K 0.21% 92
2015
Q3 		$3.09M Buy
32,040
+70
+0.2% +$7.36K 0.2% 91
2015
Q2 		$3.35M Sell
31,970
-374
-1% -$38.2K 0.18% 90
2015
Q1 		$3.34M Buy
32,344
+4,219
+15% +$427K 0.18% 90
2014
Q4 		$2.71M Buy
28,125
+11,128
+65% +$980K 0.13% 100
2014
Q3 		$1.35M Buy
+16,997
New +$1.34M 0.07% 138

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ashfield Capital Partners's CVS Position: Q1 2019 in Review

Ashfield Capital Partners sold out of CVS Health (CVS) in Q1 2019, closing a stake of 3,148 shares — an estimated $206K sold.

Ashfield Capital Partners first reported a position in CVS in Q3 2014 and held it in 13 quarters. The position peaked at $3.35M in Q2 2015. 1,707 funds tracked by Wall St. Rank hold CVS as of Q1 2019.

  • Ashfield Capital Partners reported no remaining CVS Health position as of Q1 2019 after selling out during the quarter.
  • Ashfield Capital Partners sold 3,148 CVS Health shares in Q1 2019, an estimated $206K.
  • Ashfield Capital Partners first reported a position in CVS Health in Q3 2014 and held it in 13 quarters.
  • Ashfield Capital Partners's CVS Health position peaked at $3.35M in Q2 2015.
  • 1,707 funds tracked by Wall St. Rank held CVS Health as of Q1 2019.

Based on Ashfield Capital Partners's 13F filing for Q1 2019, filed 30 Apr 2019.